2023 Publications

An acidic microenvironment in tuberculosis increases extracellular matrix degradation by regulating macrophage inflammatory responses. (2023) Whittington, A. M., Turner, F. S., Baark, F., Templeman, S., Kirwan, D. E., Roufosse, C., Krishnan, N., Robertson, B. D., Chong, D. L. W., Porter, J. C., Gilman, R. H., and Friedland, J. S. PLoS Pathog 19, e1011495: https://doi.org/10.1371/journal.ppat.1011495.

Advances in development of new tuberculosis vaccines. (2023) da Costa, C., Onyebujoh, P., Thiry, G., and Zumla, A. Curr Opin Pulm Med 29, 143-148: https://doi.org/10.1097/MCP.0000000000000950.

Artificial intelligence in paediatric tuberculosis. (2023) Naidoo, J., Shelmerdine, S. C., Charcape, C. F. U., and Sodhi, A. S. Pediatr Radiol 53, 1733-1745: https://doi.org/10.1007/s00247-023-05606-9.

Ascertainment bias in TB treatment trials: Can systematic assessment of objective endpoints solve it? (2023) Mitnick, C. D., and Nunn, A. J. Am J Respir Crit Care Med 207, 1269-1270: https://doi.org/10.1164/rccm.202303-0430ED.

An aspiration to radically shorten phase 3 tuberculosis vaccine trials. (2023) Hill, P. C., Cobelens, F., Martinez, L., Behr, M. A., Churchyard, G., Evans, T., Fiore-Gartland, A. J., Garcia-Basteiro, A. L., Hanekom, W., Rangaka, M. X., Vekemans, J., and White, R. G. J Infect Dis 228, 1150-1153: https://doi.org/10.1093/infdis/jiad356.

Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys. (2023) Hamada, Y., Quartagno, M., Law, I., Malik, F., Bonsu, F. A., Adetifa, I. M. O., Adusi-Poku, Y., D'Alessandro, U., Bashorun, A. O., Begum, V., Lolong, D. B., Boldoo, T., Dlamini, T., Donkor, S., Dwihardiani, B., Egwaga, S., Farid, M. N., Celina, G. G. A. M., Mae, G. G. D., Husain, M. M., Ismail, F., Kaggwa, M., Kamara, D. V., Kasozi, S., Kaswaswa, K., Kirenga, B., Klinkenberg, E., Kondo, Z., Lawanson, A., Macheque, D., Manhica, I., Maama-Maime, L. B., Mfinanga, S., Moyo, S., Mpunga, J., Mthiyane, T., Mustikawati, D. E., Mvusi, L., Nguyen, H. B., Nguyen, H. V., Pangaribuan, L., Patrobas, P., Rahman, M., Rahman, M., Rahman, M. S., Raleting, T., Riono, P., Ruswa, N., Rutebemberwa, E., Rwabinumi, M. F., Senkoro, M., Sharif, A. R., Sikhondze, W., Sismanidis, C., Sovd, T., Stavia, T., Sultana, S., Suriani, O., Thomas, A. M., Tobing, K., Van der Walt, M., Walusimbi, S., Zaman, M. M., Floyd, K., Copas, A., Abubakar, I., and Rangaka, M. X. EClinicalMedicine 63, 102191: https://doi.org/10.1016/j.eclinm.2023.102191.

Author Correction: Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea. (2023) Kim, H. W., Park, S., Min, J., Sun, J., Shin, A. Y., Ha, J. H., Park, J. S., Lee, S. S., Lipman, M., Abubakar, I., Stagg, H. R., and Kim, J. S. Sci Rep 13, 3028: https://doi.org/10.1038/s41598-023-30025-z.

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid. (2023) Timm, J., Bateson, A., Solanki, P., Paleckyte, A., Witney, A. A., Rofael, S. A. D., Fabiane, S., Olugbosi, M., McHugh, T. D., and Sun, E. PLOS Glob Public Health 3, e0002283: https://doi.org/10.1371/journal.pgph.0002283.

Beta-sitosterol bioconversion in small-scale devices: From microtiter plates to microfluidic reactors. (2023) Marques, M. P. C., Aranda Hernandez, J., and Fernandes, P. Methods Mol Biol 2704, 201-219: https://doi.org/10.1007/978-1-0716-3385-4_12.

Beyond latent and active tuberculosis: A scoping review of conceptual frameworks. (2023) Zaidi, S. M. A., Coussens, A. K., Seddon, J. A., Kredo, T., Warner, D., Houben, R., and Esmail, H. EClinicalMedicine 66, 102332: https://doi.org/10.1016/j.eclinm.2023.102332.

Blazing the trail for innovative tuberculosis diagnostics. (2024) Yerlikaya, S., Broger, T., Isaacs, C., Bell, D., Holtgrewe, L., Gupta-Wright, A., Nahid, P., Cattamanchi, A., and Denkinger, C. M. Infection 52, 29-42: https://doi.org/10.1007/s15010-023-02135-3.

Bolaamphiphile analogues of 12-bis-THA Cl(2) are potent antimicrobial therapeutics with distinct mechanisms of action against bacterial, mycobacterial, and fungal pathogens. (2023) Di Blasio, S., Clarke, M., Hind, C. K., Asai, M., Laurence, L., Benvenuti, A., Hassan, M., Semenya, D., Man, D. K., Horrocks, V., Manzo, G., Van Der Lith, S., Lam, C., Gentile, E., Annette, C., Bosse, J., Li, Y., Panaretou, B., Langford, P. R., Robertson, B. D., Lam, J. K. W., Sutton, J. M., McArthur, M., and Mason, A. J. mSphere 8, e0050822: https://doi.org/10.1128/msphere.00508-22.

C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists. (2023) Ferguson, L., Madieh, N. S., Vaideanu, A., Schatzlein, A., Festa, J., Singh, H., Wells, G., Bhakta, S., and Brucoli, F. Chem Biol Drug Des 101, 340-349: https://doi.org/10.1111/cbdd.14128.

Clinical standards for drug-susceptible TB in children and adolescents. (2023) Chiang, S. S., Graham, S. M., Schaaf, H. S., Marais, B. J., Sant'Anna, C. C., Sharma, S., Starke, J. R., Triasih, R., Achar, J., Amanullah, F., Armitage, L. Y., Aurilio, R. B., Buck, W. C., Centis, R., Chabala, C., Cruz, A. T., Demers, A. M., du Preez, K., Enimil, A., Furin, J., Garcia-Prats, A. J., Gonzalez, N. E., Hoddinott, G., Isaakidis, P., Jaganath, D., Kabra, S. K., Kampmann, B., Kay, A., Kitai, I., Lopez-Varela, E., Maleche-Obimbo, E., Malaspina, F. M., Velasquez, J. N., Nuttall, J. J. C., Oliwa, J. N., Andrade, I. O., Perez-Velez, C. M., Rabie, H., Seddon, J. A., Sekadde, M. P., Shen, A., Skrahina, A., Soriano-Arandes, A., Steenhoff, A. P., Tebruegge, M., Tovar, M. A., Tsogt, B., van der Zalm, M. M., Welch, H., and Migliori, G. B. Int J Tuberc Lung Dis 27, 584-598: https://doi.org/10.5588/ijtld.23.0085.

Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment. (2023) Rangaka, M. X., Frick, M., Churchyard, G., Garcia-Basteiro, A. L., Hatherill, M., Hanekom, W., Hill, P. C., Hamada, Y., Quaife, M., Vekemans, J., White, R. G., and Cobelens, F. Lancet Respir Med 11, 380-390: https://doi.org/10.1016/S2213-2600(23)00084-X.

Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults. (2023) Calderwood, C. J., Reeve, B. W., Mann, T., Palmer, Z., Nyawo, G., Mishra, H., Ndlangalavu, G., Abubakar, I., Noursadeghi, M., Theron, G., and Gupta, R. K. J Infect 86, 24-32: https://doi.org/10.1016/j.jinf.2022.10.041.

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: An individual participant data meta-analysis. (2023) Dhana, A., Gupta, R. K., Hamada, Y., Kengne, A. P., Kerkhoff, A. D., Yoon, C., Cattamanchi, A., Reeve, B. W. P., Theron, G., Ndlangalavu, G., Wood, R., Drain, P. K., Calderwood, C. J., Noursadeghi, M., Boyles, T., Meintjes, G., Maartens, G., and Barr, D. A. Eur Respir Rev 32: https://doi.org/10.1183/16000617.0021-2023.

Co-delivery of D-LAK antimicrobial peptide and capreomycin as inhaled powder formulation to combat drug-resistant tuberculosis. (2023) Shao, Z., Chow, M. Y. T., Chow, S. F., and Lam, J. K. W. Pharm Res 40, 1073-1086: https://doi.org/10.1007/s11095-023-03488-y.

Cognitive impairment in tuberculous meningitis. (2023) Davis, A. G., Dreyer, A. J., Albertyn, C., Maxebengula, M., Stek, C., Wasserman, S., Marais, S., Bateman, K., Solms, M., Joska, J., Wilkinson, R. J., and Nightingale, S. Clin Infect Dis 76, 842-849: https://doi.org/10.1093/cid/ciac831.

A comparison of phenotypic and WGS drug susceptibility testing in Mycobacterium tuberculosis isolates from the Republic of Korea. (2023) Lee, S. H., Ferran, E., Witney, A. A., Ryu, S., Kang, H., Storey, N., McHugh, T. D., and Satta, G. JAC Antimicrob Resist 5, dlad056: https://doi.org/10.1093/jacamr/dlad056.

Contributions of declining mortality, overall and from HIV, TB and malaria, to reduced health inequality and inequity across countries. (2023) Haacker, M. Health Policy Plan 38, 939-948: https://doi.org/10.1093/heapol/czad046.

COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes-a systematic review and meta-analysis. (2023) Njoku, C. M., Hurst, J. R., Kinsman, L., Balogun, S., and Obamiro, K. Thorax 78, 596-605: https://doi.org/10.1136/thorax-2022-218675.

Corrigendum: Defining discriminatory antibody fingerprints in active and latent tuberculosis. (2023) Nziza, N., Cizmeci, D., Davies, L., Irvine, E. B., Jung, W., Fenderson, B. A., de Kock, M., Hanekom, W. A., Franken, K., Day, C. L., Ottenhoff, T. H. M., and Alter, G. Front Immunol 14, 1329784: https://doi.org/10.3389/fimmu.2023.1329784.

Diabetes mellitus is not a predictor of poor TB treatment outcomes. (2023) Baltas, I., Sturdy, A., Kavallieros, K., McGregor, A., Corrah, T., John, L., Cooke, G., and Whittington, A. M. Int J Tuberc Lung Dis 27, 140-145: https://doi.org/10.5588/ijtld.22.0470.

Diagnosis and biomarkers for ocular tuberculosis: From the present into the future. (2023) Ludi, Z., Sule, A. A., Samy, R. P., Putera, I., Schrijver, B., Hutchinson, P. E., Gunaratne, J., Verma, I., Singhal, A., Nora, R. D., van Hagen, P. M., Dik, W. A., Gupta, V., and Agrawal, R. Theranostics 13, 2088-2113: https://doi.org/10.7150/thno.81488.

Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries. (2023) Olbrich, L., Verghese, V. P., Franckling-Smith, Z., Sabi, I., Ntinginya, N. E., Mfinanga, A., Banze, D., Viegas, S., Khosa, C., Semphere, R., Nliwasa, M., McHugh, T. D., Larsson, L., Razid, A., Song, R., Corbett, E. L., Nabeta, P., Trollip, A., Graham, S. M., Hoelscher, M., Geldmacher, C., Zar, H. J., Michael, J. S., Heinrich, N., and RaPaed, T. B. c. Lancet Infect Dis https://doi.org/10.1016/S1473-3099(23)00491-7.

Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. (2023) Broger, T., Koeppel, L., Huerga, H., Miller, P., Gupta-Wright, A., Blanc, F. X., Esmail, A., Reeve, B. W. P., Floridia, M., Kerkhoff, A. D., Ciccacci, F., Kasaro, M. P., Thit, S. S., Bastard, M., Ferlazzo, G., Yoon, C., Van Hoving, D. J., Sossen, B., Garcia, J. I., Cummings, M. J., Wake, R. M., Hanson, J., Cattamanchi, A., Meintjes, G., Maartens, G., Wood, R., Theron, G., Dheda, K., Olaru, I. D., Denkinger, C. M., and Consortium, T. B. S. Lancet Glob Health 11, e903-e916: https://doi.org/10.1016/S2214-109X(23)00135-3.

Digital approaches to reducing TB treatment loss to follow-up. (2023) Oeser, C., Rangaka, M. X., and Abubakar, I. Int J Tuberc Lung Dis 27, 432-437: https://doi.org/10.5588/ijtld.23.0027.

Discrepancy between Mtb-specific IFN-gamma and IgG responses in HIV-positive people with low CD4 counts. (2023) Mthembu, M., Bowman, K. A., Davies, L. R. L., Khuzwayo, S., Mazibuko, L., Bassett, T., Ramjit, D., Mhlane, Z., Karim, F., Alter, G., Ndung'u, T., and Wong, E. B. EBioMedicine 90, 104504: https://doi.org/10.1016/j.ebiom.2023.104504.

Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis. (2023) Zenner, D., Brals, D., Nederby-Ohd, J., Menezes, D., Aldridge, R., Anderson, S. R., de Vries, G., Erkens, C., Marchese, V., Matteelli, A., Muzyamba, M., van Rest, J., Spruijt, I., Were, J., Migliori, G. B., Lonnroth, K., Cobelens, F., and Abubakar, I. Eur Respir J 62: https://doi.org/10.1183/13993003.02396-2022.

Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-alpha inhibitor initiation in children in Spain. (2023) Calzada-Hernandez, J., Anton, J., Martin de Carpi, J., Lopez-Montesinos, B., Calvo, I., Donat, E., Nunez, E., Blasco Alonso, J., Mellado, M. J., Baquero-Artigao, F., Leis, R., Vegas-Alvarez, A. M., Medrano San Ildefonso, M., Pinedo-Gago, M. D. C., Eizaguirre, F. J., Tagarro, A., Camacho-Lovillo, M., Perez-Gorricho, B., Gavilan-Martin, C., Guillen, S., Sevilla-Perez, B., Pena-Quintana, L., Mesa-Del-Castillo, P., Fortuny, C., Tebruegge, M., and Noguera-Julian, A. Eur J Pediatr 182, 307-317: https://doi.org/10.1007/s00431-022-04640-3.

Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study. (2023) Gosce, L., Allel, K., Hamada, Y., Korobitsyn, A., Ismail, N., Bashir, S., Denkinger, C. M., Abubakar, I., White, P. J., and Rangaka, M. X. PLOS Glob Public Health 3, e0002573: https://doi.org/10.1371/journal.pgph.0002573.

Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. (2023) Rosu, L., Madan, J. J., Tomeny, E. M., Muniyandi, M., Nidoi, J., Girma, M., Vilc, V., Bindroo, P., Dhandhukiya, R., Bayissa, A. K., Meressa, D., Narendran, G., Solanki, R., Bhatnagar, A. K., Tudor, E., Kirenga, B., Meredith, S. K., Nunn, A. J., Bronson, G., Rusen, I. D., Squire, S. B., Worrall, E., and Collaborators, S. S. H. E. E. Lancet Glob Health 11, e265-e277: https://doi.org/10.1016/S2214-109X(22)00498-3.

The effect of M. tuberculosis lineage on clinical phenotype. (2023) Du, D. H., Geskus, R. B., Zhao, Y., Codecasa, L. R., Cirillo, D. M., van Crevel, R., Pascapurnama, D. N., Chaidir, L., Niemann, S., Diel, R., Omar, S. V., Grandjean, L., Rokadiya, S., Ortitz, A. T., Lan, N. H., Ha, D. T. M., Smith, E. G., Robinson, E., Dedicoat, M., Nhat, L. T. H., Thwaites, G. E., Van, L. H., Thuong, N. T. T., and Walker, T. M. PLOS Glob Public Health 3, e0001788: https://doi.org/10.1371/journal.pgph.0001788.

Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa. (2023) du Bruyn, E., Stek, C., Daroowala, R., Said-Hartley, Q., Hsiao, M., Schafer, G., Goliath, R. T., Abrahams, F., Jackson, A., Wasserman, S., Allwood, B. W., Davis, A. G., Lai, R. P., Coussens, A. K., Wilkinson, K. A., de Vries, J., Tiffin, N., Cerrone, M., Ntusi, N. A. B., consortium, H., Riou, C., and Wilkinson, R. J. Nat Commun 14, 188: https://doi.org/10.1038/s41467-022-35689-1.

Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. (2023) Galileya, L. T., Wasmann, R. E., Chabala, C., Rabie, H., Lee, J., Njahira Mukui, I., Hesseling, A., Zar, H., Aarnoutse, R., Turkova, A., Gibb, D., Cotton, M. F., McIlleron, H., and Denti, P. PLoS Med 20, e1004303: https://doi.org/10.1371/journal.pmed.1004303.

Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses. (2023) Krause, R., Warren, C. M., Simmons, J. D., Rebeiro, P. F., Maruri, F., Karim, F., Sterling, T. R., Koethe, J. R., Leslie, A., and van der Heijden, Y. F. Front Immunol 14, 1151528: https://doi.org/10.3389/fimmu.2023.1151528.

A flexible multi-metric Bayesian framework for decision-making in Phase II multi-arm multi-stage studies. (2024) Dufault, S. M., Crook, A. M., Rolfe, K., and Phillips, P. P. J. Stat Med 43, 501-513: https://doi.org/10.1002/sim.9961.

Forgiveness is the attribute of the strong: Nonadherence and regimen shortening in drug-sensitive tuberculosis. (2023) Stagg, H. R., Thompson, J. A., Lipman, M. C. I., Sloan, D. J., Flook, M., and Fielding, K. L. Am J Respir Crit Care Med 207, 193-205: https://doi.org/10.1164/rccm.202201-0144OC.

Genome-wide association with uncertainty in the genetic similarity matrix. (2023) Wang, S., Ge, S., Sobkowiak, B., Wang, L., Grandjean, L., Colijn, C., and Elliott, L. T. J Comput Biol 30, 189-203: https://doi.org/10.1089/cmb.2022.0067.

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. (2023) Achar, J., Seddon, J. A., Knight, G. M., Dodd, P. J., Esmail, H., Hughes, J., and McQuaid, C. F. Eur Respir J: https://doi.org/10.1183/13993003.00969-2023.

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study. (2023) Rehal, S., Cro, S., Phillips, P. P., Fielding, K., and Carpenter, J. R. Clin Trials 20, 497-506: https://doi.org/10.1177/17407745231176773.

Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: A systematic review. (2021) Baggaley, R. F., Vegvari, C., Dimala, C. A., Lipman, M., Miller, R. F., Brown, J., Degtyareva, S., White, H. A., Hollingsworth, T. D., and Pareek, M. Wellcome Open Res 6, 51: https://doi.org/10.12688/wellcomeopenres.16604.2.

Identification and control for the effects of bioinformatic globin depletion on human RNA-seq differential expression analysis. (2023) Sheerin, D., Lakay, F., Esmail, H., Kinnear, C., Sansom, B., Glanzmann, B., Wilkinson, R. J., Ritchie, M. E., and Coussens, A. K. Sci Rep 13, 1859: https://doi.org/10.1038/s41598-023-28218-7.

Impact of COVID-19 on NHS tuberculosis services: Results of a UK-wide survey. (2023) Morrison, H., Perrin, F., Dedicoat, M., Ahmed, R., Brown, J., Loughenbury, M., Paul, S., Souto, M., Ward, R., and Lipman, M. J Infect: https://doi.org/10.1016/j.jinf.2023.04.004.

Implementation challenges and lessons learned from the STREAM clinical trial-a survey of trial sites. (2023) Patel, L. N., Gurumurthy, M., Bronson, G., Sanders, K., and Rusen, I. D. Trials 24, 51: https://doi.org/10.1186/s13063-023-07068-8.

Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation. (2023) Dodd, P. J., McQuaid, C. F., Rao, P., Abubakar, I., Arinaminpathy, N., Carnegie, A., Cobelens, F., Dowdy, D., Fiekert, K., Grant, A. D., Wu, J., Nfii, F. N., Shaikh, N., Houben, R., and White, R. G. Int J Epidemiol: https://doi.org/10.1093/ije/dyad128.

Inadequate Lopinavir concentrations with modified 8-hourly Lopinavir/Ritonavir 4:1 dosing during rifampicin-based tuberculosis treatment in children living with HIV. (2023) Chabala, C., Turkova, A., Kapasa, M., LeBeau, K., Tembo, C. H., Zimba, K., Weisner, L., Zyambo, K., Choo, L., Chungu, C., Lungu, J., Mulenga, V., Crook, A., Gibb, D., McIlleron, H., and team, S. t. Pediatr Infect Dis J 42, 899-904: https://doi.org/10.1097/INF.0000000000004047.

Indirect effects of cytomegalovirus infection: Implications for vaccine development. (2023) Moseley, P., Klenerman, P., and Kadambari, S. Rev Med Virol 33, e2405: https://doi.org/10.1002/rmv.2405.

Infective native extracranial carotid artery aneurysms: A systematic review. (2023) Hanger, M., and Baker, D. M. Ann Vasc Surg 91, 275-286: https://doi.org/10.1016/j.avsg.2022.11.028.

Integrating molecular microbial methods to improve faecal pollution management in rivers with designated bathing waters. (2024) Karunakaran, E., Battarbee, R., Tait, S., Brentan, B. M., Berney, C., Grinham, J., Herrero, M. A., Omolo, R., and Douterelo, I. Sci Total Environ 912, 168565: https://doi.org/10.1016/j.scitotenv.2023.168565.

Interventions to reduce deaths in people living with HIV admitted to hospital in low- and middle-income countries: A systematic review. (2023) Burke, R. M., Twabi, H. H., Johnston, C., Nliwasa, M., Gupta-Wright, A., Fielding, K., Ford, N., MacPherson, P., and Corbett, E. L. PLOS Glob Public Health 3, e0001557: https://doi.org/10.1371/journal.pgph.0001557.

Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis. (2023) Abdelgawad, N., Wasserman, S., Abdelwahab, M. T., Davis, A., Stek, C., Wiesner, L., Black, J., Meintjes, G., Wilkinson, R. J., and Denti, P. J Infect Dis: https://doi.org/10.1093/infdis/jiad413.

Long-term outcomes after tuberculosis for people with HIV in eastern Europe. (2023) Kraef, C., Bentzon, A., Roen, A., Bolokadze, N., Thompson, M., Azina, I., Tetradov, S., Skrahina, A., Karpov, I., Mitsura, V., Paduto, D., Trofimova, T., Borodulina, E., Mocroft, A., Kirk, O., Podlekareva, D. N., and group, T. H. s. AIDS: https://doi.org/10.1097/QAD.0000000000003670.

Management of nontuberculous mycobacteria-pulmonary disease: Results from the first UK survey of clinical practice. (2023) Malhotra, A. M., Bryant, S., Kunst, H., Haworth, C. S., Lipman, M., and UK, N. T. M. N. J Infect: https://doi.org/10.1016/j.jinf.2023.04.009.

Mapping the phylogeny and lineage history of geographically distinct BCG vaccine strains. (2023) Elton, L., Kasaragod, S., Donoghue, H., Safar, H. A., Amankwah, P., Zumla, A., Witney, A. A., and McHugh, T. D. Microb Genom 9: https://doi.org/10.1099/mgen.0.001077.

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: Why and how? (2023) Nelson, K. N., Churchyard, G., Cobelens, F., Hanekom, W. A., Hill, P. C., Lopman, B., Mave, V., Rangaka, M. X., Vekemans, J., White, R. G., Wong, E. B., Martinez, L., and Garcia-Basteiro, A. L. Lancet Microbe 4, e651-e656: https://doi.org/10.1016/S2666-5247(23)00112-X.

The natural history of untreated pulmonary tuberculosis in adults: A systematic review and meta-analysis. (2023) Sossen, B., Richards, A. S., Heinsohn, T., Frascella, B., Balzarini, F., Oradini-Alacreu, A., Odone, A., Rogozinska, E., Hacker, B., Cobelens, F., Kranzer, K., Houben, R., and Esmail, H. Lancet Respir Med 11, 367-379: https://doi.org/10.1016/S2213-2600(23)00097-8.

Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: A diagnostic accuracy study. (2023) Huerga, H., Bastard, M., Lubega, A. V., Akinyi, M., Antabak, N. T., Ohler, L., Muyindike, W., Taremwa, I. M., Stewart, R., Bossard, C., Nkosi, N., Ndlovu, Z., Hewison, C., Stavia, T., Okomo, G., Ogoro, J. O., Ngozo, J., Mbatha, M., Aleny, C., Wanjala, S., Musoke, M., Atwine, D., Ascorra, A., Ardizzoni, E., Casenghi, M., Ferlazzo, G., Nakiyingi, L., Gupta-Wright, A., and Bonnet, M. Lancet Glob Health 11, e126-e135: https://doi.org/10.1016/S2214-109X(22)00463-6.

Optimizing outcomes for high-risk, non-muscle-invasive bladder cancer: The evolving role of PD-(L)1 inhibition. (2023) Bedke, J., Black, P. C., Szabados, B., Guerrero-Ramos, F., Shariat, S. F., Xylinas, E., Brinkmann, J., Blake-Haskins, J. A., Cesari, R., and Redorta, J. P. Urol Oncol 41, 461-475: https://doi.org/10.1016/j.urolonc.2023.10.004.

Outcomes of a residential respite service for homeless people with tuberculosis in London, UK: A cross-sectional study. (2023) Crosby, L., Lewer, D., Appleby, Y., Anderson, C., Hayward, A., and Story, A. Perspect Public Health 143, 89-96: https://doi.org/10.1177/17579139221093544.

Patients' priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia. (2023) South, A., Dhesi, P., Tweed, C. D., Tsogt, B., Staples, S., Tukvadze, N., Dorj, G., Zaca, S., Sanikidze, E., Purev, N., Esmail, H., and Burgess, R. Glob Public Health 18, 2234450: https://doi.org/10.1080/17441692.2023.2234450.

Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: A multicentre PTBNET study. (2023) Buonsenso, D., Noguera-Julian, A., Moroni, R., Hernandez-Bartolome, A., Fritschi, N., Lancella, L., Cursi, L., Soler-Garcia, A., Kruger, R., Feiterna-Sperling, C., Sali, M., Lo Vecchio, A., Scarano, S., Hernanz Lobo, A., Espiau, M., Soriano-Arandes, A., Cetin, B. S., Brinkmann, F., Ozere, I., Baquero-Artigao, F., Tsolia, M., Milheiro Silva, T., Bustillo-Alonso, M., Martin Nalda, A., Mancini, M., Starshinova, A., Ritz, N., Velizarova, S., Ferreras-Antolin, L., Gotzinger, F., Bilogortseva, O., Chechenyeva, V., Tebruegge, M., Santiago-Garcia, B., and ptbnet, Q. F. T. P. s. g. Thorax 78, 288-296: https://doi.org/10.1136/thorax-2022-218929.

A Phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus-associated tuberculous meningitis: The LASER-TBM trial. (2023) Davis, A. G., Wasserman, S., Stek, C., Maxebengula, M., Jason Liang, C., Stegmann, S., Koekemoer, S., Jackson, A., Kadernani, Y., Bremer, M., Daroowala, R., Aziz, S., Goliath, R., Lai Sai, L., Sihoyiya, T., Denti, P., Lai, R. P. J., Crede, T., Naude, J., Szymanski, P., Vallie, Y., Banderker, I. A., Moosa, M. S., Raubenheimer, P., Candy, S., Offiah, C., Wahl, G., Vorster, I., Maartens, G., Black, J., Meintjes, G., and Wilkinson, R. J. Clin Infect Dis 76, 1412-1422: https://doi.org/10.1093/cid/ciac932.

A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis. (2023) Dierig, A., Hoelscher, M., Schultz, S., Hoffmann, L., Jarchow-MacDonald, A., Svensson, E. M., Te Brake, L., Aarnoutse, R., Boeree, M., McHugh, T. D., Wildner, L. M., Gong, X., Phillips, P., Minja, L. T., Ntinginya, N., Mpagama, S., Liyoyo, A., Wallis, R. S., Sebe, M., Mhimbira, F. A., Mbeya, B., Rassool, M., Geiter, L., Cho, Y. L., and Heinrich, N. Trials 24, 382: https://doi.org/10.1186/s13063-023-07354-5.

Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: Implications for a diagnostic accuracy. (2024) Qadir, M., Faryal, R., Khan, M. T., Khan, S. A., Zhang, S., Li, W., Wei, D. Q., Tahseen, S., and McHugh, T. D. Microbiol Spectr 12, e0163123: https://doi.org/10.1128/spectrum.01631-23.

Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis. (2023) Hamada, Y., Gupta, R. K., Quartagno, M., Izzard, A., Acuna-Villaorduna, C., Altet, N., Diel, R., Dominguez, J., Floyd, S., Gupta, A., Huerga, H., Jones-Lopez, E. C., Kinikar, A., Lange, C., van Leth, F., Liu, Q., Lu, W., Lu, P., Rueda, I. L., Martinez, L., Mbandi, S. K., Munoz, L., Padilla, E. S., Paradkar, M., Scriba, T., Sester, M., Shanaube, K., Sharma, S. K., Sloot, R., Sotgiu, G., Thiruvengadam, K., Vashishtha, R., Abubakar, I., and Rangaka, M. X. EClinicalMedicine 56, 101815: https://doi.org/10.1016/j.eclinm.2022.101815.

Premature termination of transcription is shaped by Rho and translated uORFS in Mycobacterium tuberculosis. (2023) D'Halluin, A., Polgar, P., Kipkorir, T., Patel, Z., Cortes, T., and Arnvig, K. B. iScience 26, 106465: https://doi.org/10.1016/j.isci.2023.106465.

Prevalence and characteristics of non-tuberculous mycobacteria (NTM) infection in recipients of allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. (2023) Cinicola, B. L., Ottaviano, G., Hashim, I. F., Zainudeen, Z. T., Hamid, I. J. A., and Elfeky, R. J Clin Immunol 44, 23: https://doi.org/10.1007/s10875-023-01615-3.

Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: A systematic review and meta-analysis. (2023) Oh, A. L., Makmor-Bakry, M., Islahudin, F., and Wong, I. C. BMJ Glob Health 8: https://doi.org/10.1136/bmjgh-2022-010592.

Previous BCG vaccination is associated with less severe clinical progression of COVID-19. (2023) Pereira, S. M., Barreto, F. R., de Souza, R. A., de Souza Teles Santos, C. A., Pereira, M., da Paixao, E. S., de Jesus Lima, C. C. O., da Natividade, M. S., Lindoso, A., Fernandes, E. G., Junior, E. B. C., Pescarini, J. M., de Andrade, K. V. F., de Souza, F. M., de Britto, E. A., Nunes, C., Ichihara, M. Y., Dalcolmo, M., Trajman, A., Barral-Netto, M., Abubakar, I., Barreto, M. L., de Alencar Ximenes, R. A., and Rodrigues, L. C. BMC Med 21, 145: https://doi.org/10.1186/s12916-023-02859-x.

Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment. (2023) Narayan, A., Salindri, A. D., Keshavjee, S., Muyoyeta, M., Velen, K., Rueda, Z. V., Croda, J., Charalambous, S., Garcia-Basteiro, A. L., Shenoi, S. V., Goncalves, C. C. M., Ferreira da Silva, L., Possuelo, L. G., Aguirre, S., Estigarribia, G., Sequera, G., Grandjean, L., Telisinghe, L., Herce, M. E., Dockhorn, F., Altice, F. L., and Andrews, J. R. PLoS Med 20, e1004288: https://doi.org/10.1371/journal.pmed.1004288.

The problem of Mycobacterium abscessus complex: Multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission. (2023) Dedrick, R. M., Abad, L., Storey, N., Kaganovsky, A. M., Smith, B. E., Aull, H. A., Cristinziano, M., Morkowska, A., Murthy, S., Loebinger, M. R., Hatfull, G. F., and Satta, G. Clin Microbiol Infect 29, 1335 e1339-1335 e1316: https://doi.org/10.1016/j.cmi.2023.06.026.

Psychosocial support interventions to improve treatment outcomes for people living with tuberculosis: A mixed methods systematic review and meta-analysis. (2023) Maynard, C., Tariq, S., Sotgiu, G., Migliori, G. B., van den Boom, M., and Field, N. EClinicalMedicine 61, 102057: https://doi.org/10.1016/j.eclinm.2023.102057.

Public health benefits of shifting from hospital-focused to ambulatory TB care in Eastern Europe: Optimising TB investments in Belarus, the Republic of Moldova, and Romania. (2023) Kelly, S. L., Jaoude, G. J. A., Palmer, T., Skordis, J., Haghparast-Bidgoli, H., Gosce, L., Jarvis, S. J., Kedziora, D. J., Abeysuriya, R., Benedikt, C., Fraser-Hurt, N., Shubber, Z., Cheikh, N., Bivol, S., Roberts, A., Wilson, D. P., and Martin-Hughes, R. PLOS Glob Public Health 3, e0001025: https://doi.org/10.1371/journal.pgph.0001025.

Pyrimidine derivatives with antitubercular activity. (2023) Finger, V., Kufa, M., Soukup, O., Castagnolo, D., Roh, J., and Korabecny, J. Eur J Med Chem 246, 114946: https://doi.org/10.1016/j.ejmech.2022.114946.

Quantifying progression and regression across the spectrum of pulmonary tuberculosis: A data synthesis study. (2023) Richards, A. S., Sossen, B., Emery, J. C., Horton, K. C., Heinsohn, T., Frascella, B., Balzarini, F., Oradini-Alacreu, A., Hacker, B., Odone, A., McCreesh, N., Grant, A. D., Kranzer, K., Cobelens, F., Esmail, H., and Houben, R. Lancet Glob Health 11, e684-e692: https://doi.org/10.1016/S2214-109X(23)00082-7.

Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis. (2023) Horton, K. C., Richards, A. S., Emery, J. C., Esmail, H., and Houben, R. Proc Natl Acad Sci U S A 120, e2221186120: https://doi.org/10.1073/pnas.2221186120.

Regimens for drug-resistant tuberculosis. Reply. (2023) Timm, J., Crook, A. M., and Sun, E. N Engl J Med 388, 190-191: https://doi.org/10.1056/NEJMc2213970.

Reply: Tuberculosis screening in migrants to the EU/EEA and UK. (2023) Zenner, D., Cobelens, F., and Abubakar, I. Eur Respir J 62: https://doi.org/10.1183/13993003.01535-2023.

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease. (2023) Alkarni, M., Lipman, M., and Lowe, D. M. Ann Clin Microbiol Antimicrob 22, 14: https://doi.org/10.1186/s12941-023-00562-6.

Scaling up evidence-based approaches to tuberculosis screening in prisons. (2023) Charalambous, S., Velen, K., Rueda, Z., Croda, J., Herce, M. E., Shenoi, S. V., Altice, F. L., Muyoyeta, M., Telisinghe, L., Grandjean, L., Keshavjee, S., and Andrews, J. R. Lancet Public Health: https://doi.org/10.1016/S2468-2667(23)00002-6.

Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings. (2024) van Geuns, D., Arts, R. J. W., de Vries, G., Wit, F., Degtyareva, S. Y., Brown, J., Pareek, M., Lipman, M., and van Crevel, R. AIDS 38, 193-205: https://doi.org/10.1097/QAD.0000000000003747.

Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): An open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial. (2023) Nyang'wa, B. T., Berry, C., Kazounis, E., Motta, I., Parpieva, N., Tigay, Z., Moodliar, R., Dodd, M., Solodovnikova, V., Liverko, I., Rajaram, S., Rassool, M., McHugh, T., Spigelman, M., Moore, D. A., Ritmeijer, K., du Cros, P., Fielding, K., and team, T.-P. Lancet Respir Med: https://doi.org/10.1016/S2213-2600(23)00389-2.

Standards for clinical trials for treating TB. (2023) du Cros, P., Greig, J., Alffenaar, J. C., Cross, G. B., Cousins, C., Berry, C., Khan, U., Phillips, P. P. J., Velasquez, G. E., Furin, J., Spigelman, M., Denholm, J. T., Thi, S. S., Tiberi, S., Huang, G. K. L., Marks, G. B., Turkova, A., Guglielmetti, L., Chew, K. L., Nguyen, H. T., Ong, C. W. M., Brigden, G., Singh, K. P., Motta, I., Lange, C., Seddon, J. A., Nyang'wa, B. T., Maug, A. K. J., Gler, M. T., Dooley, K. E., Quelapio, M., Tsogt, B., Menzies, D., Cox, V., Upton, C. M., Skrahina, A., McKenna, L., Horsburgh, C. R., Dheda, K., and Marais, B. J. Int J Tuberc Lung Dis 27, 885-898: https://doi.org/10.5588/ijtld.23.0341.

Stress granules plug and stabilize damaged endolysosomal membranes. (2023) Bussi, C., Mangiarotti, A., Vanhille-Campos, C., Aylan, B., Pellegrino, E., Athanasiadi, N., Fearns, A., Rodgers, A., Franzmann, T. M., Saric, A., Dimova, R., and Gutierrez, M. G. Nature 623, 1062-1069: https://doi.org/10.1038/s41586-023-06726-w.

Synthesis and anti-Mycobacterium tuberculosis activity of imidazo[2,1-b][1,3]oxazine derivatives against multidrug-resistant strains. (2023) Fernandes, G. F. S., Manieri, K. F., Bonjorno, A. F., Campos, D. L., Ribeiro, C. M., Demarqui, F. M., Ruiz, D. A. G., Nascimento-Junior, N. M., Denny, W. A., Thompson, A. M., Pavan, F. R., and Dos Santos, J. L. ChemMedChem, e202300015: https://doi.org/10.1002/cmdc.202300015.

Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex. (2023) Murnane, R., Zloh, M., Tanna, S., Allen, R., Santana-Gomez, F., Parish, T., and Brucoli, F. Bioorg Chem 138, 106659: https://doi.org/10.1016/j.bioorg.2023.106659.

A systematic review on the safety of Mycobacterium tuberculosis-specific antigen-based skin tests for tuberculosis infection compared with tuberculin skin tests. (2023) Hamada, Y., Kontsevaya, I., Surkova, E., Wang, T. T., Wan-Hsin, L., Matveev, A., Ziganshina, L. E., Denkinger, C. M., Korobitsyn, A., Ismail, N., Abubakar, I., and Rangaka, M. X. Open Forum Infect Dis 10, ofad228: https://doi.org/10.1093/ofid/ofad228.

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. (2023) Musvosvi, M., Huang, H., Wang, C., Xia, Q., Rozot, V., Krishnan, A., Acs, P., Cheruku, A., Obermoser, G., Leslie, A., Behar, S. M., Hanekom, W. A., Bilek, N., Fisher, M., Kaufmann, S. H. E., Walzl, G., Hatherill, M., Davis, M. M., Scriba, T. J., Adolescent Cohort Study, t., and Consortium, G. C. Nat Med 29, 258-269: https://doi.org/10.1038/s41591-022-02110-9.

Target product profiles: tests for tuberculosis treatment monitoring and optimization. (2023) Gupta-Wright, A., den Boon, S., MacLean, E. L., Cirillo, D., Cobelens, F., Gillespie, S. H., Kohli, M., Ruhwald, M., Savic, R., Brigden, G., Gidado, M., Goletti, D., Hanna, D., Hasan, R., Hewison, C., Koura, K. G., Lienhardt, C., Lungu, P., McHugh, T. D., McKenna, L., Scott, C., Scriba, T., Sekaggya-Wiltshire, C., Kasaeva, T., Zignol, M., Denkinger, C. M., and Falzon, D. Bull World Health Organ 101, 730-737: https://doi.org/10.2471/BLT.23.290901.

Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies. (2023) Sharma, S., Chikhale, R., Shinde, N., Khan, A. M., and Gupta, V. K. Front Cell Infect Microbiol 13, 1111997: https://doi.org/10.3389/fcimb.2023.1111997.

Time to change the way we think about tuberculosis infection prevention and control in health facilities: Insights from recent research. (2023) Yates, T. A., Karat, A. S., Bozzani, F., McCreesh, N., MacGregor, H., Beckwith, P. G., Govender, I., Colvin, C. J., Kielmann, K., and Grant, A. D. Antimicrob Steward Healthc Epidemiol 3, e117: https://doi.org/10.1017/ash.2023.192.

Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis. (2023) Gray, A. T., Macpherson, L., Carlin, F., Sossen, B., Richards, A. S., Kik, S. V., Houben, R., MacPherson, P., Quartagno, M., Rogozinska, E., and Esmail, H. PLoS One 18, e0293535: https://doi.org/10.1371/journal.pone.0293535.

Treatment Strategy for Rifampin-Susceptible Tuberculosis. (2023) Paton, N. I., Cousins, C., Suresh, C., Burhan, E., Chew, K. L., Dalay, V. B., Lu, Q., Kusmiati, T., Balanag, V. M., Lee, S. L., Ruslami, R., Pokharkar, Y., Djaharuddin, I., Sugiri, J. J. R., Veto, R. S., Sekaggya-Wiltshire, C., Avihingsanon, A., Sarin, R., Papineni, P., Nunn, A. J., Crook, A. M., and Team, T.-T. T. N Engl J Med: https://doi.org/10.1056/NEJMoa2212537.

Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac). (2023) Li, X., Peng, K., Cheng, F. W. T., Lam, D. C. L., Cheung, C. L., Chui, C. S. L., Lai, F. T. T., Wan, E. Y. F., Wong, C. K. H., Ma, T., Yum, S. H. H., Chan, E. W. Y., Huang, J. D., Lau, C. S., Ip, M. S. M., and Wong, I. C. K. J Infect 86, 256-308: https://doi.org/10.1016/j.jinf.2022.12.016.

Tuberculosis prevention: current strategies and future directions. (2023) Vasiliu, A., Martinez, L., Gupta, R. K., Hamada, Y., Ness, T., Kay, A., Bonnet, M., Sester, M., Kaufmann, S. H. E., Lange, C., and Mandalakas, A. M. Clin Microbiol Infecthttps://doi.org/10.1016/j.cmi.2023.10.023.

Using a whole genome co-expression network to inform the functional characterisation of predicted genomic elements from Mycobacterium tuberculosis transcriptomic data. (2023) Stiens, J., Tan, Y. Y., Joyce, R., Arnvig, K. B., Kendall, S. L., and Nobeli, I. Mol Microbiol 119, 381-400: https://doi.org/10.1111/mmi.15055.

Validation of proteins associated with pathological damage in human tuberculosis granulomas: Study protocol. (2023) Mpotje, T., More, J., Rajkumar-Bhugeloo, K., Moodley, D., and Marakalala, M. J. Wellcome Open Res 8, 139: https://doi.org/10.12688/wellcomeopenres.19226.1.

The value of the second QuantiFERON-TB Gold-Plus antigen tube at diagnosis and at treatment completion in Spanish children with tuberculosis. (2023) Soler-Garcia, A., Gamell, A., Monsonis, M., Korta-Murua, J. J., Espiau, M., Rincon-Lopez, E., Rodriguez-Molino, P., Perez-Porcuna, T., Bustillo-Alonso, M., Santiago, B., Tebruegge, M., Noguera-Julian, A., and Network, Q. F.-P. S. G. o. t. S. P. T. R. Pediatr Infect Dis J: https://doi.org/10.1097/INF.0000000000004058.

World tuberculosis day 2023 - Reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populations. (2023) Rodriguez-Morales, A. J., Abbara, A., Ntoumi, F., Kapata, N., Mwaba, P., Yeboah-Manu, D., Maeurer, M., Dar, O., Abubakar, I., and Zumla, A. Travel Med Infect Dis 53, 102568: https://doi.org/10.1016/j.tmaid.2023.102568.

World Tuberculosis Day 2023 theme "Yes! We can end TB!". (2023) Goletti, D., Al-Abri, S., Migliori, G. B., Coler, R., Ong, C. W. M., Esposito, S. M. R., Tadolini, M., Matteelli, A., Cirillo, D., Nemes, E., Zumla, A., and Petersen, E. Int J Infect Dis: https://doi.org/10.1016/j.ijid.2023.04.006.

Other Outputs

Blog posts

Learning to embrace the blips: the highs and lows of running workshops. Linzy Elton. April 2023. Link

Challenges of combatting tuberculosis in Gabon. Pacome Abdul. May 2023. Link

TB at the UN 2023. Marc Lipman. October 2023. Link

YouTube videos

Studying substance use in tuberculosis transmission and outcomes in South Africa. Dr Karen Jacobson. Jan 2023. Link 

Bedaquiline: What might the future hold? Webinar co-hosted by UCL-TB and AHRI. Link

Launch of WHO UCL Collaborative Centre on TB Research & Innovation. Link

Transcripts

Bedaquiline: What might the future hold? Webinar co-hosted by UCL-TB and AHRI. https://doi.org/10.5522/04/24866250

Back to top